The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies

The following paper links the medicalization with daily oral hormonal feminine contraception and its process of risk assessment, issues whose importance has grown in the public debates of the last decades. From this point of view, diverse “paradigms” get shaped across the time, as ways of prioritizi...

Descripción completa

Detalles Bibliográficos
Autor principal: Alpe, Ángeles
Formato: Artículo revista
Lenguaje:Español
Publicado: Facultad de Humanidades y Artes. UNR 2019
Materias:
Acceso en línea:https://zonafranca.unr.edu.ar/index.php/ZonaFranca/article/view/112
Aporte de:
id I15-R214-article-112
record_format ojs
spelling I15-R214-article-1122020-04-06T19:23:49Z The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies La evaluación de riesgo en el ámbito de la anticoncepción hormonal oral regular femenina: panorama de controversias actuales. Alpe, Ángeles Hormonal feminine contraception – Risk assessment – Gender evaluación de riesgo anticoncepción hormonal femenina género The following paper links the medicalization with daily oral hormonal feminine contraception and its process of risk assessment, issues whose importance has grown in the public debates of the last decades. From this point of view, diverse “paradigms” get shaped across the time, as ways of prioritizing benefits or side effects in the commercialization or administration of the “pill”. Those go together, of course, with the evolution of sexual and reproductive health models. This capital dimension of analysis, brings to light the risk, not only as an objective fact, but also and mostly as a result of the intersection of socio-cultural, economic and politic factors. Dimension which takes also place in a vast literature that questions the feminine hormonal contraception, its liberalizing quality for women and its role perpetuating gender inequalities.  El presente artículo vincula la medicalización con anticonceptivos hormonales orales regulares femeninos y sus procesos de evaluación de riesgo (o risk assessment), temas de protagonismo creciente en los debates públicos de las últimas décadas. Desde esta perspectiva, diversos “paradigmas” se dibujan a lo largo de los años, en tanto formas de priorizar beneficios o efectos secundarios a la hora de comercializar o administrar “la píldora”, y que van de la mano, por supuesto, de la evolución de los modelos de salud sexual y reproductiva. Esta dimensión clave a estudiar pone de manifiesto el riesgo no solo como un dato objetivo sino, y sobre todo, como resultado del cruce de factores socioculturales, económicos y políticos. Dimensión que se inscribe, a su vez, en una amplia bibliografía que ha problematizado la anticoncepción hormonal femenina entre su cualidad liberadora de la mujer y su rol perpetuador de desigualdades de género. Facultad de Humanidades y Artes. UNR 2019-12-16 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf text/html https://zonafranca.unr.edu.ar/index.php/ZonaFranca/article/view/112 10.35305/zf.v0i27.112 Zona Franca; No. 27 (2019); 240-258 Zona Franca; Núm. 27 (2019); 240-258 Zona Franca; Núm. 27 (2019); 240-258 2545-6504 0329-8019 spa https://zonafranca.unr.edu.ar/index.php/ZonaFranca/article/view/112/107 https://zonafranca.unr.edu.ar/index.php/ZonaFranca/article/view/112/108 Derechos de autor 2019 Ángeles Alpe
institution Universidad Nacional de Rosario
institution_str I-15
repository_str R-214
container_title_str Zona Franca
language Español
format Artículo revista
topic Hormonal feminine contraception – Risk assessment – Gender
evaluación de riesgo
anticoncepción hormonal femenina
género
spellingShingle Hormonal feminine contraception – Risk assessment – Gender
evaluación de riesgo
anticoncepción hormonal femenina
género
Alpe, Ángeles
The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
topic_facet Hormonal feminine contraception – Risk assessment – Gender
evaluación de riesgo
anticoncepción hormonal femenina
género
author Alpe, Ángeles
author_facet Alpe, Ángeles
author_sort Alpe, Ángeles
title The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
title_short The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
title_full The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
title_fullStr The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
title_full_unstemmed The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
title_sort risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
description The following paper links the medicalization with daily oral hormonal feminine contraception and its process of risk assessment, issues whose importance has grown in the public debates of the last decades. From this point of view, diverse “paradigms” get shaped across the time, as ways of prioritizing benefits or side effects in the commercialization or administration of the “pill”. Those go together, of course, with the evolution of sexual and reproductive health models. This capital dimension of analysis, brings to light the risk, not only as an objective fact, but also and mostly as a result of the intersection of socio-cultural, economic and politic factors. Dimension which takes also place in a vast literature that questions the feminine hormonal contraception, its liberalizing quality for women and its role perpetuating gender inequalities. 
publisher Facultad de Humanidades y Artes. UNR
publishDate 2019
url https://zonafranca.unr.edu.ar/index.php/ZonaFranca/article/view/112
work_keys_str_mv AT alpeangeles theriskassessmentofdailyoralhormonalfemininecontraceptionanoverviewofcurrentcontroversies
AT alpeangeles laevaluacionderiesgoenelambitodelaanticoncepcionhormonaloralregularfemeninapanoramadecontroversiasactuales
AT alpeangeles riskassessmentofdailyoralhormonalfemininecontraceptionanoverviewofcurrentcontroversies
first_indexed 2023-05-11T18:53:48Z
last_indexed 2023-05-11T18:53:48Z
_version_ 1765625014598500352